US2985589A
(en)
*
|
1957-05-22 |
1961-05-23 |
Universal Oil Prod Co |
Continuous sorption process employing fixed bed of sorbent and moving inlets and outlets
|
US3632836A
(en)
|
1968-10-25 |
1972-01-04 |
Dow Chemical Co |
Solid curable polyepoxides modified with hydrolyzed liquid polyepoxides
|
US3832460A
(en)
|
1971-03-19 |
1974-08-27 |
C Kosti |
Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
|
US4140755A
(en)
|
1976-02-13 |
1979-02-20 |
Hoffmann-La Roche Inc. |
Sustained release tablet formulations
|
DE3036390A1
(de)
|
1980-09-26 |
1982-05-13 |
Troponwerke GmbH & Co KG, 5000 Köln |
Neue pyrrolo-pyrimidine, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung von biologischen wirkstoffen
|
DE3220113A1
(de)
*
|
1982-05-28 |
1983-12-01 |
Basf Ag, 6700 Ludwigshafen |
Difluormethoxiphenylthiophosphorsaeureester
|
US4402832A
(en)
*
|
1982-08-12 |
1983-09-06 |
Uop Inc. |
High efficiency continuous separation process
|
US4404335A
(en)
|
1982-08-16 |
1983-09-13 |
The Dow Chemical Company |
Hydrolyzing epoxy resins in absence of solvent and in presence of oxalic acid and a phosphonium compound
|
US4548990A
(en)
|
1983-08-15 |
1985-10-22 |
Ciba-Geigy Corporation |
Crosslinked, porous polymers for controlled drug delivery
|
US4498991A
(en)
*
|
1984-06-18 |
1985-02-12 |
Uop Inc. |
Serial flow continuous separation process
|
NL8403224A
(nl)
*
|
1984-10-24 |
1986-05-16 |
Oce Andeno Bv |
Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
|
CA1306260C
(en)
|
1985-10-18 |
1992-08-11 |
Shionogi & Co., Ltd. |
Condensed imidazopyridine derivatives
|
JPH0710876Y2
(ja)
|
1989-08-31 |
1995-03-15 |
石垣機工株式会社 |
スクリュープレスにおける脱水筒の洗浄装置
|
DK0495982T3
(da)
*
|
1989-10-11 |
1996-07-01 |
Teijin Ltd |
Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
|
US5403593A
(en)
|
1991-03-04 |
1995-04-04 |
Sandoz Ltd. |
Melt granulated compositions for preparing sustained release dosage forms
|
IT1258781B
(it)
*
|
1992-01-16 |
1996-02-29 |
Zambon Spa |
Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
FR2695126B1
(fr)
|
1992-08-27 |
1994-11-10 |
Sanofi Elf |
Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant.
|
AU671491B2
(en)
|
1992-12-18 |
1996-08-29 |
F. Hoffmann-La Roche Ag |
N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
|
JPH0710876A
(ja)
|
1993-06-24 |
1995-01-13 |
Teijin Ltd |
4位に環状アミノ基を有するピロロ[2,3―d]ピリミジン
|
USH1439H
(en)
|
1993-10-18 |
1995-05-02 |
The Dow Chemical Company |
Method to increase the level of α-glycol in liquid epoxy resin
|
EP0727217A3
(en)
|
1995-02-10 |
1997-01-15 |
Suntory Ltd |
Pharmaceutical and cosmetic compositions containing God-type ellagitannin as an active ingredient
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
US5856326A
(en)
*
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
AU6478396A
(en)
|
1995-07-05 |
1997-02-05 |
E.I. Du Pont De Nemours And Company |
Fungicidal pyrimidinones
|
CA2224435C
(en)
|
1995-07-06 |
2008-08-05 |
Novartis Ag |
Pyrrolopyrimidines and processes for the preparation thereof
|
US5630943A
(en)
*
|
1995-11-30 |
1997-05-20 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Discontinuous countercurrent chromatographic process and apparatus
|
GB9604361D0
(en)
|
1996-02-29 |
1996-05-01 |
Pharmacia Spa |
4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors
|
CA2250232A1
(en)
|
1996-04-03 |
1997-10-09 |
Allen I. Oliff |
A method of treating cancer
|
JP2000513711A
(ja)
|
1996-04-18 |
2000-10-17 |
メルク エンド カンパニー インコーポレーテッド |
癌の治療法
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
WO1997045412A1
(en)
|
1996-05-30 |
1997-12-04 |
Merck & Co., Inc. |
A method of treating cancer
|
US6624138B1
(en)
|
2001-09-27 |
2003-09-23 |
Gp Medical |
Drug-loaded biological material chemically treated with genipin
|
JP2001524079A
(ja)
|
1997-04-07 |
2001-11-27 |
メルク エンド カンパニー インコーポレーテッド |
ガンの治療方法
|
US6060038A
(en)
|
1997-05-15 |
2000-05-09 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
US6063284A
(en)
|
1997-05-15 |
2000-05-16 |
Em Industries, Inc. |
Single column closed-loop recycling with periodic intra-profile injection
|
EP1001782A4
(en)
*
|
1997-08-11 |
2002-01-30 |
Boehringer Ingelheim Pharma |
5,6-HETEROARYL-DIPYRIDO (2-3-b: 3 ', 2'-f) AZEPINS AND THE USE THEREOF FOR PROPHYLAXIS AND TREATMENT OF HIV INFECTIONS
|
US7153845B2
(en)
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6075056A
(en)
|
1997-10-03 |
2000-06-13 |
Penederm, Inc. |
Antifungal/steroid topical compositions
|
US6025366A
(en)
|
1998-04-02 |
2000-02-15 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
BR9910864A
(pt)
|
1998-06-04 |
2002-02-05 |
Abbott Lab |
Compostos anti-inflamatórios para inibição de aderência celular
|
US6232320B1
(en)
*
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
ATE265458T1
(de)
|
1998-06-19 |
2004-05-15 |
Pfizer Prod Inc |
Pyrrolo(2,3-d)pyrimidin-verbindungen
|
JP4516690B2
(ja)
|
1998-08-11 |
2010-08-04 |
ノバルティス アーゲー |
血管形成阻害活性を有するイソキノリン誘導体
|
JP2000119271A
(ja)
|
1998-08-12 |
2000-04-25 |
Hokuriku Seiyaku Co Ltd |
1h―イミダゾピリジン誘導体
|
CA2343148C
(en)
|
1998-09-10 |
2005-11-15 |
Nycomed Danmark A/S |
Quick release pharmaceutical compositions of drug substances
|
US6413419B1
(en)
*
|
1998-10-29 |
2002-07-02 |
Institut Francais Du Petrole |
Process and device for separation with variable-length chromatographic
|
US6375839B1
(en)
*
|
1998-10-29 |
2002-04-23 |
Institut Francais Du Petrole |
Process and device for separation with variable-length chromatographic zones
|
FR2785196B1
(fr)
|
1998-10-29 |
2000-12-15 |
Inst Francais Du Petrole |
Procede et dispositif de separation avec des zones chromatographiques a longueur variable
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
CA2362495A1
(en)
|
1999-03-03 |
2000-09-08 |
Theresa M. Williams |
Inhibitors of prenyl-protein transferases
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6239113B1
(en)
*
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
AU3565999A
(en)
|
1999-04-16 |
2000-11-02 |
Coelacanth Chemical Corporation |
Synthesis of azetidine derivatives
|
US6915718B2
(en)
*
|
1999-09-02 |
2005-07-12 |
United Parts Fhs Automobil Systeme Gmbh |
Selector handle in a motor vehicle
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
DE60013464T2
(de)
*
|
1999-10-13 |
2005-09-15 |
Banyu Pharmaceutical Co., Ltd. |
Substituierte imidazolin-derivate
|
US7235258B1
(en)
|
1999-10-19 |
2007-06-26 |
Nps Pharmaceuticals, Inc. |
Sustained-release formulations for treating CNS-mediated disorders
|
DK1235830T3
(da)
|
1999-12-10 |
2004-03-29 |
Pfizer Prod Inc |
Pyrrolo[2,3-d]pyrimidin-forbindelser som proteinkinaseinhibitorer
|
CA2699568C
(en)
|
1999-12-24 |
2013-03-12 |
Aventis Pharma Limited |
Azaindoles
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
US7235551B2
(en)
*
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
TR200302105T4
(tr)
|
2000-04-07 |
2004-02-23 |
Laboratoire Medidom S. A. |
Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
|
AU4878601A
(en)
|
2000-04-20 |
2001-11-07 |
Mitsubishi Corporation |
Aromatic amide compounds
|
SI2223922T1
(sl)
|
2000-04-25 |
2016-04-29 |
Icos Corporation |
Inhibitorji humane fosfatidil-inositol 3-kinazne delta izoforme
|
AU7549501A
(en)
|
2000-06-16 |
2002-01-02 |
Biogen Inc |
Angiogenesis-modulating compositions and uses
|
US7498304B2
(en)
*
|
2000-06-16 |
2009-03-03 |
Curis, Inc. |
Angiogenesis-modulating compositions and uses
|
US6335342B1
(en)
|
2000-06-19 |
2002-01-01 |
Pharmacia & Upjohn S.P.A. |
Azaindole derivatives, process for their preparation, and their use as antitumor agents
|
JP5000831B2
(ja)
*
|
2000-06-23 |
2012-08-15 |
田辺三菱製薬株式会社 |
抗腫瘍作用増強剤
|
MXPA03000068A
(es)
|
2000-06-26 |
2003-09-25 |
Pfizer Prod Inc |
Compuestos de pirrolo (2,3-d)pirimidina como agentes inmunosupresores.
|
WO2002000196A2
(en)
|
2000-06-28 |
2002-01-03 |
Smithkline Beecham P.L.C. |
Wet milling process
|
AU2001278790A1
(en)
|
2000-08-22 |
2002-03-04 |
Hokuriku Seiyaku Co. Ltd |
1h-imidazopyridine derivatives
|
WO2002046184A1
(en)
|
2000-12-05 |
2002-06-13 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
GB0100622D0
(en)
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds V111
|
EP1351936A1
(en)
*
|
2001-01-15 |
2003-10-15 |
Glaxo Group Limited |
Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
|
EP1363702A4
(en)
|
2001-01-30 |
2007-08-22 |
Cytopia Pty Ltd |
PROCESS FOR INHIBITING KINASES
|
EP1404669A2
(en)
|
2001-05-16 |
2004-04-07 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
|
US7301023B2
(en)
|
2001-05-31 |
2007-11-27 |
Pfizer Inc. |
Chiral salt resolution
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
WO2003011285A1
(en)
|
2001-08-01 |
2003-02-13 |
Merck & Co., Inc. |
BENZIMIDAZO[4,5-f]ISOQUINOLINONE DERIVATIVES
|
EP1436291B1
(en)
|
2001-09-19 |
2009-01-14 |
Aventis Pharma S.A. |
Indolizines as kinase protein inhibitors
|
US6429231B1
(en)
|
2001-09-24 |
2002-08-06 |
Bradley Pharmaceuticals, Inc. |
Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
|
DK1441737T3
(da)
|
2001-10-30 |
2006-11-13 |
Novartis Ag |
Staurosporin-derivater som inhibitorer af FLT3-receptor-tyrosinkinase-aktivitet
|
JP2003155285A
(ja)
|
2001-11-19 |
2003-05-27 |
Toray Ind Inc |
環状含窒素誘導体
|
KR20040058340A
(ko)
*
|
2001-11-30 |
2004-07-03 |
데이진 가부시키가이샤 |
5-(3-시아노페닐)-3-포르밀벤조산 화합물의 제조 방법
|
GT200200234A
(es)
|
2001-12-06 |
2003-06-27 |
|
Compuestos cristalinos novedosos
|
US6995144B2
(en)
*
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
WO2003088952A1
(en)
|
2002-04-15 |
2003-10-30 |
Adams Laboratories, Inc. |
Sustained release of guaifenesin combination drugs
|
TW200403058A
(en)
*
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
WO2003091246A1
(en)
*
|
2002-04-26 |
2003-11-06 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
ATE381332T1
(de)
|
2002-05-02 |
2008-01-15 |
Merck & Co Inc |
Tyrosinkinase-hemmer
|
WO2003094888A1
(en)
*
|
2002-05-07 |
2003-11-20 |
Control Delivery Systems, Inc. |
Processes for forming a drug delivery device
|
IL165264A0
(en)
|
2002-05-23 |
2005-12-18 |
Cytopia Pty Ltd |
Protein kinase inhibitors
|
AR037647A1
(es)
|
2002-05-29 |
2004-12-01 |
Novartis Ag |
Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
|
WO2004003026A1
(ja)
|
2002-06-26 |
2004-01-08 |
Idemitsu Kosan Co., Ltd. |
共重合体水素添加物、その製造方法及びそれを用いたホットメルト接着剤組成物
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
GB0215844D0
(en)
*
|
2002-07-09 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
JPWO2004007472A1
(ja)
*
|
2002-07-10 |
2005-11-17 |
小野薬品工業株式会社 |
Ccr4アンタゴニストおよびその医薬用途
|
CN1684738A
(zh)
|
2002-09-20 |
2005-10-19 |
爱尔康公司 |
细胞因子合成抑制剂用于治疗干眼病的用途
|
US20040204404A1
(en)
|
2002-09-30 |
2004-10-14 |
Robert Zelle |
Human N-type calcium channel blockers
|
CA2506773A1
(en)
|
2002-11-04 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl-pyramidine derivatives as jak inhibitors
|
US8034831B2
(en)
|
2002-11-06 |
2011-10-11 |
Celgene Corporation |
Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
|
CL2003002353A1
(es)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
US20040099204A1
(en)
|
2002-11-25 |
2004-05-27 |
Nestor John J. |
Sheet, page, line, position marker
|
WO2004047843A1
(en)
|
2002-11-26 |
2004-06-10 |
Pfizer Products Inc. |
Method of treatment of transplant rejection
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
UY28126A1
(es)
*
|
2002-12-24 |
2004-06-30 |
Alcon Inc |
Uso de glucocorticoides selectivos para la superficie ocular en el tratamiento de la sequedad ocular
|
TW200418806A
(en)
|
2003-01-13 |
2004-10-01 |
Fujisawa Pharmaceutical Co |
HDAC inhibitor
|
US7167750B2
(en)
|
2003-02-03 |
2007-01-23 |
Enteromedics, Inc. |
Obesity treatment with electrically induced vagal down regulation
|
EP1611125A1
(en)
|
2003-02-07 |
2006-01-04 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl substituted pyrolls useful as inhibitors of protein kinases
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
JP2006522124A
(ja)
|
2003-04-03 |
2006-09-28 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用な組成物
|
SE0301373D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
SE0301372D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
FR2857454B1
(fr)
|
2003-07-08 |
2006-08-11 |
Aventis Pasteur |
Dosage des acides techoiques des bacteries gram+
|
US20050043346A1
(en)
|
2003-08-08 |
2005-02-24 |
Pharmacia Italia S.P.A. |
Pyridylpyrrole derivatives active as kinase inhibitors
|
US8362017B2
(en)
|
2003-08-29 |
2013-01-29 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
WO2005026129A1
(en)
|
2003-09-15 |
2005-03-24 |
Gpc Biotech Ag |
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
ES2357801T3
(es)
*
|
2003-10-24 |
2011-04-29 |
Santen Pharmaceutical Co., Ltd. |
Agente terapéutico para trastorno queratoconjuntival.
|
US7387793B2
(en)
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
CA2545192A1
(en)
|
2003-11-25 |
2005-06-09 |
Pfizer Products Inc. |
Method of treatment of atherosclerosis
|
CN1893952A
(zh)
|
2003-12-17 |
2007-01-10 |
辉瑞产品公司 |
用于治疗移植排斥的吡咯并[2,3-d]嘧啶化合物
|
CN1918138B
(zh)
|
2003-12-19 |
2011-05-04 |
先灵公司 |
作为cxc-和cc-趋化因子受体配体的噻二唑化合物
|
CA2550361C
(en)
|
2003-12-19 |
2014-04-29 |
Prabha Ibrahim |
Compounds and methods for development of ret modulators
|
US8247576B2
(en)
|
2003-12-23 |
2012-08-21 |
Astex Therapeutics Limited |
Pyrazole derivatives as protein kinase modulators
|
US20050165029A1
(en)
*
|
2004-01-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
|
US20050277629A1
(en)
|
2004-03-18 |
2005-12-15 |
The Brigham And Women's Hospital, Inc. |
Methods for the treatment of synucleinopathies (Lansbury)
|
DK1730146T3
(da)
|
2004-03-30 |
2011-08-15 |
Vertex Pharma |
Azaindoler anvendelige som inhibitorer af JAK og andre proteinkinaser
|
CA2563699C
(en)
|
2004-04-23 |
2014-03-25 |
Exelixis, Inc. |
Kinase modulators and method of use
|
US7558717B2
(en)
|
2004-04-28 |
2009-07-07 |
Vertex Pharmaceuticals Incorporated |
Crystal structure of human JAK3 kinase domain complex and binding pockets thereof
|
WO2005105814A1
(en)
*
|
2004-04-28 |
2005-11-10 |
Incyte Corporation |
Tetracyclic inhibitors of janus kinases
|
MXPA06012663A
(es)
|
2004-05-03 |
2007-01-16 |
Novartis Ag |
Combinaciones que comprenden un agonista del receptor s1p y un inhibidor de quinasa jak3.
|
EP1753428A4
(en)
|
2004-05-14 |
2010-09-15 |
Abbott Lab |
INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
|
PE20060426A1
(es)
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
MY144044A
(en)
|
2004-06-10 |
2011-07-29 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
US8039674B2
(en)
*
|
2004-06-23 |
2011-10-18 |
Ono Pharmaceutical Co., Ltd. |
Compound having S1P receptor binding potency and use thereof
|
AU2005260689B2
(en)
|
2004-06-30 |
2012-05-10 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of protein kinases
|
US7138423B2
(en)
|
2004-07-20 |
2006-11-21 |
Bristol-Myers Squibb Company |
Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
|
FR2873691B1
(fr)
*
|
2004-07-29 |
2006-10-06 |
Sanofi Synthelabo |
Derives d'amino-piperidine, leur preparation et leur application en therapeutique
|
WO2006013114A1
(en)
|
2004-08-06 |
2006-02-09 |
Develogen Aktiengesellschaft |
Use of a timp-2 secreted protein product for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
|
WO2006022459A1
(en)
|
2004-08-23 |
2006-03-02 |
Mogam Biotechnology Institute |
Primer and probe for detection of sars coronavirus, kit comprising the primer and/or the probe, and detection method thereof
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
JP2008515939A
(ja)
*
|
2004-10-13 |
2008-05-15 |
エフ.ホフマン−ラ ロシュ アーゲー |
Cdk2及び血管形成の阻害剤として、及び乳癌、結腸癌及び前立腺癌の治療に有用な2置換ピラゾロベンゾジアゼピン
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
AU2005304784B2
(en)
*
|
2004-11-04 |
2011-03-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
|
EP1885352A2
(en)
|
2004-11-24 |
2008-02-13 |
Novartis AG |
Combinations comprising jak inhibitors and at least one of bcr-abl, flt-3, fak or raf kinase inhibitors
|
US7517870B2
(en)
*
|
2004-12-03 |
2009-04-14 |
Fondazione Telethon |
Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
|
WO2006065916A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Alcon, Inc. |
Method of treating dry eye disorders using 13(s)-hode and its analogs
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
TW200635899A
(en)
|
2004-12-22 |
2006-10-16 |
Astrazeneca Ab |
Chemical compounds
|
JP2008528477A
(ja)
|
2005-01-20 |
2008-07-31 |
ファイザー・リミテッド |
化合物
|
KR20070104641A
(ko)
*
|
2005-02-03 |
2007-10-26 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제의 억제제로 유용한 피롤로피리미딘
|
US7683171B2
(en)
|
2005-02-04 |
2010-03-23 |
Bristol-Myers Squibb Company |
1H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
|
AU2006227790B2
(en)
|
2005-03-15 |
2009-09-10 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
JP2008534689A
(ja)
|
2005-04-05 |
2008-08-28 |
ファーマコペイア, インコーポレイテッド |
免疫抑制のためのプリン及びイミダゾピリジン誘導体
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
CN101228161B
(zh)
*
|
2005-05-20 |
2012-10-10 |
沃泰克斯药物股份有限公司 |
适用作蛋白激酶抑制剂的吡咯并吡啶类
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
SG137989A1
(en)
|
2005-06-08 |
2008-01-28 |
Rigel Pharmaceuticals Inc |
Compositions and methods for inhibition of the JAK pathway
|
WO2006136823A1
(en)
|
2005-06-21 |
2006-12-28 |
Astex Therapeutics Limited |
Heterocyclic containing amines as kinase b inhibitors
|
TWI432193B
(zh)
|
2005-06-22 |
2014-04-01 |
Plexxikon Inc |
用於激酶調節的化合物及方法及其適應症
|
EP2251341A1
(en)
|
2005-07-14 |
2010-11-17 |
Astellas Pharma Inc. |
Heterocyclic Janus kinase 3 inhibitors
|
FR2889662B1
(fr)
|
2005-08-11 |
2011-01-14 |
Galderma Res & Dev |
Emulsion de type huile-dans-eau pour application topique en dermatologie
|
US20070049591A1
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Inhibitors of MAPK/Erk Kinase
|
JP5119154B2
(ja)
*
|
2005-09-22 |
2013-01-16 |
インサイト・コーポレイション |
Janusキナーゼの四環系阻害剤
|
ZA200802685B
(en)
|
2005-09-30 |
2009-10-28 |
Vertex Pharma |
Deazapurines useful as inhibitors of janus kinases
|
WO2007044894A2
(en)
|
2005-10-11 |
2007-04-19 |
Chembridge Research Laboratories, Inc. |
Cell-free protein expression systems and methods of use thereof
|
AU2006300182B2
(en)
|
2005-10-14 |
2012-01-19 |
Sumitomo Chemical Company, Limited |
Hydrazide compound and pesticidal use of the same
|
RU2463302C2
(ru)
|
2005-10-28 |
2012-10-10 |
Астразенека Аб |
Производные 4-(3-аминопиразол)пиримидина для применения в качестве ингибиторов тирозинкиназы для лечения злокачественного новообразования
|
EP1951684B1
(en)
*
|
2005-11-01 |
2016-07-13 |
TargeGen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
ES2481671T3
(es)
|
2005-11-21 |
2014-07-31 |
Novartis Ag |
Inhibidores de mTOR en el tratamiento de tumores endocrinos
|
WO2007062459A1
(en)
|
2005-11-29 |
2007-06-07 |
Cytopia Research Pty Ltd |
Selective kinase inhibitors based on pyridine scaffold
|
US20130137681A1
(en)
*
|
2005-12-13 |
2013-05-30 |
Incyte Corporation |
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
|
KR101324737B1
(ko)
*
|
2005-12-13 |
2013-11-05 |
인사이트 코포레이션 |
야누스 키나아제 억제제로서의 헤테로아릴 치환된 피롤로[2,3-b]피리딘 및 피롤로[2,3-b]피리미딘
|
JP2009521504A
(ja)
|
2005-12-22 |
2009-06-04 |
スミスクライン・ビーチャム・コーポレイション |
Akt活性阻害剤
|
WO2007076348A2
(en)
*
|
2005-12-23 |
2007-07-05 |
Smithkline Beecham Corporation |
Azaindole inhibitors of aurora kinases
|
JP4643455B2
(ja)
|
2006-01-12 |
2011-03-02 |
株式会社ユニバーサルエンターテインメント |
遊技システム
|
CN102532133A
(zh)
|
2006-01-17 |
2012-07-04 |
沃泰克斯药物股份有限公司 |
适用作詹纳斯激酶抑制剂的吖吲哚类
|
WO2007084667A2
(en)
*
|
2006-01-19 |
2007-07-26 |
Osi Pharmaceutical, Inc. |
Fused heterobicyclic kinase inhibitors
|
WO2007090141A2
(en)
|
2006-02-01 |
2007-08-09 |
Smithkline Beecham Corporation |
Pyrrolo [2, 3, b] pyridine derivatives useful as raf kinase inhibitors
|
US7745477B2
(en)
|
2006-02-07 |
2010-06-29 |
Hoffman-La Roche Inc. |
Heteroaryl and benzyl amide compounds
|
WO2007097770A1
(en)
|
2006-02-24 |
2007-08-30 |
Teva Pharmaceutical Industries Ltd. |
Metoprolol succinate e.r. tablets and methods for their preparation
|
EA200870344A1
(ru)
*
|
2006-03-10 |
2009-04-28 |
Оно Фармасьютикал Ко., Лтд. |
Азотсодержащее гетероциклическое производное и фармацевтическое средство, включающее такое производное в качестве активного ингредиента
|
BRPI0709866B8
(pt)
*
|
2006-04-03 |
2021-05-25 |
Astellas Pharma Inc |
compostos héteros e composição farmacêutica compreendendo ditos compostos
|
EP2001884A1
(en)
*
|
2006-04-05 |
2008-12-17 |
Vertex Pharmaceuticals, Inc. |
Deazapurines useful as inhibitors of janus kinases
|
US20090124636A1
(en)
|
2006-04-12 |
2009-05-14 |
Pfizer Inc. |
Chemical compounds
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
CA2652751A1
(en)
|
2006-05-18 |
2007-11-29 |
Bayer Healthcare Ag |
Pharmaceutical compositions and methods of using same
|
US7691811B2
(en)
*
|
2006-05-25 |
2010-04-06 |
Bodor Nicholas S |
Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
|
TWI398252B
(zh)
|
2006-05-26 |
2013-06-11 |
Novartis Ag |
吡咯并嘧啶化合物及其用途
|
NZ573174A
(en)
|
2006-06-01 |
2012-01-12 |
Msd Consumer Care Inc |
Sustained release pharmaceutical dosage form containing phenylephrine
|
CN101790527A
(zh)
*
|
2006-07-20 |
2010-07-28 |
凯利普西斯公司 |
Rho激酶的苯并噻吩抑制剂
|
WO2008013622A2
(en)
|
2006-07-27 |
2008-01-31 |
E. I. Du Pont De Nemours And Company |
Fungicidal azocyclic amides
|
US8492378B2
(en)
*
|
2006-08-03 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
GSK-3β inhibitor
|
US8318723B2
(en)
*
|
2006-08-16 |
2012-11-27 |
Boehringer Ingelheim International Gmbh |
Pyrazine compounds, their use and methods of preparation
|
CA2662091A1
(en)
|
2006-09-08 |
2008-03-13 |
Novartis Ag |
N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
|
WO2008035376A2
(en)
|
2006-09-19 |
2008-03-27 |
Council Of Scientific & Industrial Research |
A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof
|
CL2007002866A1
(es)
|
2006-10-04 |
2008-07-04 |
Pharmacopeia Inc |
Compuestos derivados de 6-sustituidos-2-(bencimidazolil) purina y purinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades autoinmunes, enfermedad inflamatoria, enfermedad mediada por m
|
CL2007002867A1
(es)
*
|
2006-10-04 |
2008-06-27 |
Pharmacopeia Inc |
Compuestos derivados de 2-(bencimidazolil)purina, inhibidores de janus quinasa 3; composicion farmaceutica que los contiene; y su uso para tratar enfermedades autoinmune, inflamatorias, cardiovasculares, rechazo de implante, entre otras.
|
US20120225057A1
(en)
|
2006-10-11 |
2012-09-06 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
SG176461A1
(en)
|
2006-11-06 |
2011-12-29 |
Supergen Inc |
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
|
US20080119496A1
(en)
*
|
2006-11-16 |
2008-05-22 |
Pharmacopeia Drug Discovery, Inc. |
7-Substituted Purine Derivatives for Immunosuppression
|
MY188335A
(en)
|
2006-11-22 |
2021-11-30 |
Incyte Holdings Corp |
Imidazotriazines and imidazopyrimidines as kinase inhibitors
|
WO2008067119A2
(en)
|
2006-11-27 |
2008-06-05 |
Smithkline Beecham Corporation |
Novel compounds
|
SG177221A1
(en)
|
2006-12-15 |
2012-01-30 |
Abbott Lab |
Novel oxadiazole compounds
|
CA2672903C
(en)
*
|
2006-12-20 |
2012-10-23 |
Amgen Inc. |
Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
|
WO2008079291A2
(en)
|
2006-12-20 |
2008-07-03 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
JP5315252B2
(ja)
|
2006-12-22 |
2013-10-16 |
シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ |
眼科用薬物の輸送に有用なゲル
|
EP2121692B1
(en)
*
|
2006-12-22 |
2013-04-10 |
Incyte Corporation |
Substituted heterocycles as janus kinase inhibitors
|
WO2008082840A1
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
KR20080062876A
(ko)
|
2006-12-29 |
2008-07-03 |
주식회사 대웅제약 |
신규한 항진균성 트리아졸 유도체
|
WO2008082839A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
US8822497B2
(en)
|
2007-03-01 |
2014-09-02 |
Novartis Ag |
PIM kinase inhibitors and methods of their use
|
CA2682981C
(en)
|
2007-04-03 |
2015-11-17 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
US8188178B2
(en)
|
2007-05-07 |
2012-05-29 |
3M Innovative Properties Company |
Cold shrinkable article including an epichlorohydrin composition
|
GB0709031D0
(en)
|
2007-05-10 |
2007-06-20 |
Sareum Ltd |
Pharmaceutical compounds
|
US8653262B2
(en)
|
2007-05-31 |
2014-02-18 |
Boehringer Ingelheim International Gmbh |
CCR2 receptor antagonists and uses thereof
|
GB0710528D0
(en)
|
2007-06-01 |
2007-07-11 |
Glaxo Group Ltd |
Novel compounds
|
CU24179B1
(es)
|
2007-06-13 |
2016-04-25 |
Incyte Corp |
SALES DE ÁCIDO MALEICO Y DE ÁCIDO SULFÚRICO DE (R)-3-(4-(7H-PIRROLO[2,3-d]PIRIMIDIN-4-IL)-1H-PIRAZOL-1-IL)-3-CICLOPENTILPROPANITRILO
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
KR20120115413A
(ko)
|
2007-07-11 |
2012-10-17 |
화이자 인코포레이티드 |
안구 건조증 치료용 약학 조성물 및 방법
|
WO2009016460A2
(en)
|
2007-08-01 |
2009-02-05 |
Pfizer Inc. |
Pyrazole compounds and their use as raf inhibitors
|
WO2009049028A1
(en)
|
2007-10-09 |
2009-04-16 |
Targegen Inc. |
Pyrrolopyrimidine compounds and their use as janus kinase modulators
|
EP2217235A4
(en)
|
2007-11-15 |
2011-01-12 |
Musc Found For Res Dev |
PROTEIN INHIBITORS PIM KINASES, COMPOSITIONS AND METHODS FOR TREATING CANCER
|
US8309718B2
(en)
|
2007-11-16 |
2012-11-13 |
Incyte Corporation |
4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
|
GB0723815D0
(en)
|
2007-12-05 |
2008-01-16 |
Glaxo Group Ltd |
Compounds
|
SI2231689T1
(sl)
*
|
2008-01-18 |
2016-11-30 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Novi citostatski 7-deazapurinski nukleozidi
|
MX2010008376A
(es)
|
2008-02-04 |
2011-02-22 |
Mercury Therapeutics Inc |
Moduladores ampk.
|
AR070531A1
(es)
|
2008-03-03 |
2010-04-14 |
Novartis Ag |
Inhibidores de cinasa pim y metodos para su uso
|
MY165582A
(en)
|
2008-03-11 |
2018-04-05 |
Incyte Holdings Corp |
Azetidine and cyclobutane derivatives as jak inhibitors
|
BRPI0908906A2
(pt)
|
2008-03-21 |
2019-09-24 |
Novartis Ag |
compostos heterocíclicos e usos dos mesmos
|
WO2009155156A1
(en)
|
2008-06-18 |
2009-12-23 |
Merck & Co., Inc. |
Inhibitors of janus kinases
|
US20110212157A1
(en)
|
2008-06-26 |
2011-09-01 |
Anterios, Inc. |
Dermal delivery
|
UY31952A
(es)
|
2008-07-02 |
2010-01-29 |
Astrazeneca Ab |
5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
|
FR2933409B1
(fr)
|
2008-07-03 |
2010-08-27 |
Centre Nat Rech Scient |
NOUVEAUX PYRROLO °2,3-a! CARBAZOLES ET LEUR UTILISATION COMME INHIBITEURS DES KINASES PIM
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之三唑吡啶化合物
|
WO2010022081A1
(en)
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
MX2011001904A
(es)
|
2008-08-20 |
2011-03-29 |
Pfizer |
Compuestos de pirrolo[2,3-d]pirimidina.
|
CN102203079B
(zh)
|
2008-09-02 |
2014-12-10 |
诺华股份有限公司 |
作为激酶抑制剂的吡啶甲酰胺衍生物
|
KR20110056399A
(ko)
|
2008-09-02 |
2011-05-27 |
노파르티스 아게 |
헤테로시클릭 pim-키나제 억제제
|
EA201100426A1
(ru)
|
2008-09-02 |
2011-10-31 |
Новартис Аг |
Бициклические ингибиторы киназы
|
CL2009001884A1
(es)
*
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
EP2350054A4
(en)
|
2008-10-17 |
2012-03-28 |
Merck Canada Inc |
AZETIDINE DERIVATIVES AS INHIBITORS OF THE STEAROYL COENZYME A DELTA 9 DESATURASE
|
JOP20190231A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
EP2210890A1
(en)
|
2009-01-19 |
2010-07-28 |
Almirall, S.A. |
Oxadiazole derivatives as S1P1 receptor agonists
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
BRPI1012159B1
(pt)
|
2009-05-22 |
2022-01-25 |
Incyte Holdings Corporation |
Compostos derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d] pirimidinas e pirrol-3-il-pirrolo[2,3-d] pirimidinas como inibidores de janus cinase, composições farmacêuticas compreendendo os referidos compostos e usos dos mesmos
|
EA020494B1
(ru)
|
2009-05-22 |
2014-11-28 |
Инсайт Корпорейшн |
3-[4-(7H-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1H-ПИРАЗОЛ-1-ИЛ]ОКТАН- ИЛИ ГЕПТАННИТРИЛ КАК JAK-ИНГИБИТОРЫ
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
TW201105674A
(en)
|
2009-07-08 |
2011-02-16 |
Leo Pharma As |
Novel JAK receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof
|
WO2011066371A2
(en)
|
2009-11-24 |
2011-06-03 |
Alder Biopharmaceuticals, Inc. |
Antibodies to il-6 and use thereof
|
US20120157500A1
(en)
|
2009-08-24 |
2012-06-21 |
Weikang Tao |
Jak inhibition blocks rna interference associated toxicities
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
TW201113285A
(en)
*
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
EP2475659B1
(en)
|
2009-09-08 |
2015-10-28 |
F.Hoffmann-La Roche Ag |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
EP2305660A1
(en)
|
2009-09-25 |
2011-04-06 |
Almirall, S.A. |
New thiadiazole derivatives
|
KR101921850B1
(ko)
|
2009-10-09 |
2018-11-23 |
인사이트 홀딩스 코포레이션 |
3-(4-(7H-피롤로〔2,3-d〕피리미딘-4-일)-1H-피라졸-1-일)-3-사이클로펜틸프로판니트릴의 하이드록실, 케토 및 글루쿠로나이드 유도체
|
AR078675A1
(es)
|
2009-10-20 |
2011-11-23 |
Cellzome Ltd |
Derivados de pirazolo[3,4-d]pirimidina inhibidores de jak quinasas, composiciones farmaceuticas que los comprenden, metodo para prepararlos y uso de los mismos para el tratamiento o profilaxis de trastornos inmunologicos, inflamatorios y autoinmunes.
|
US20110113416A1
(en)
|
2009-11-09 |
2011-05-12 |
Bank Of America Corporation |
Network-Enhanced Control Of Software Updates Received Via Removable Computer-Readable Medium
|
EP2332917B1
(en)
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
WO2011069141A2
(en)
|
2009-12-04 |
2011-06-09 |
Board Of Regents, The University Of Texas System |
Interferon therapies in combination with blockade of stat3 activation
|
WO2011075334A1
(en)
|
2009-12-18 |
2011-06-23 |
Pfizer Inc. |
Pyrrolo[2,3-d]pyrimidine compounds
|
CA2781578A1
(en)
|
2010-01-12 |
2011-07-21 |
F. Hoffmann-La Roche Ag |
Tricyclic heterocyclic compounds, compositions and methods of use thereof
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
JP5858434B2
(ja)
|
2010-02-18 |
2016-02-10 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Janusキナーゼ阻害薬としてのシクロブタンおよびメチルシクロブタン誘導体
|
NO3050882T3
(ko)
*
|
2010-03-10 |
2018-06-30 |
|
|
US8962596B2
(en)
|
2010-04-14 |
2015-02-24 |
Array Biopharma Inc. |
5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases
|
EP2390252A1
(en)
|
2010-05-19 |
2011-11-30 |
Almirall, S.A. |
New pyrazole derivatives
|
EP2574168B9
(en)
|
2010-05-21 |
2016-10-05 |
Incyte Holdings Corporation |
Topical formulation for a jak inhibitor
|
WO2011156698A2
(en)
|
2010-06-11 |
2011-12-15 |
Abbott Laboratories |
NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS
|
US9351943B2
(en)
|
2010-07-01 |
2016-05-31 |
Matthew T. McLeay |
Anti-fibroblastic fluorochemical emulsion therapies
|
US20130252917A1
(en)
|
2010-09-30 |
2013-09-26 |
Portola Pharmaceuticals, Inc. |
Combination therapy of 4-(3-(2h-1,2,3-triazo-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide and fludarabine
|
WO2012068440A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
UA113156C2
(xx)
|
2010-11-19 |
2016-12-26 |
|
Циклобутилзаміщені похідні піролопіридину й піролопіримідину як інгібітори jak
|
NZ611654A
(en)
|
2010-12-03 |
2015-08-28 |
Ym Biosciences Australia Pty |
Treatment of jak2-mediated conditions
|
ES2547916T3
(es)
*
|
2011-02-18 |
2015-10-09 |
Novartis Pharma Ag |
Terapia de combinación de inhibidores de mTOR/JAK
|
CN102247368B
(zh)
|
2011-05-19 |
2013-05-29 |
安徽永生堂药业有限责任公司 |
一种复方阿伐斯汀缓释片及其制备方法
|
CN102218042A
(zh)
|
2011-05-26 |
2011-10-19 |
青岛黄海制药有限责任公司 |
富马酸喹硫平组合物的缓释片剂及其制备方法
|
EA201490042A1
(ru)
|
2011-06-20 |
2014-10-30 |
Инсайт Корпорейшн |
Азетидинил-фенил-, пиридил- или пиразинилкарбоксамидные производные как ингибиторы jak
|
WO2013007765A1
(en)
|
2011-07-13 |
2013-01-17 |
F. Hoffmann-La Roche Ag |
Fused tricyclic compounds for use as inhibitors of janus kinases
|
WO2013007768A1
(en)
|
2011-07-13 |
2013-01-17 |
F. Hoffmann-La Roche Ag |
Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
|
WO2013023119A1
(en)
|
2011-08-10 |
2013-02-14 |
Novartis Pharma Ag |
JAK P13K/mTOR COMBINATION THERAPY
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
US9193733B2
(en)
|
2012-05-18 |
2015-11-24 |
Incyte Holdings Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
US10155987B2
(en)
|
2012-06-12 |
2018-12-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of predicting resistance to JAK inhibitor therapy
|
PL3450434T3
(pl)
|
2012-06-15 |
2021-10-04 |
Concert Pharmaceuticals, Inc. |
Deuterowane pochodne ruksolitynibu
|
US20150246043A1
(en)
|
2012-07-27 |
2015-09-03 |
Ratiopharm Gmbh |
Oral dosage forms for modified release comprising ruxolitinib
|
CN102772384A
(zh)
|
2012-08-07 |
2012-11-14 |
四川百利药业有限责任公司 |
一种盐酸米诺环素缓释片及其制备方法
|
WO2014036016A1
(en)
|
2012-08-31 |
2014-03-06 |
Principia Biopharma Inc. |
Benzimidazole derivatives as itk inhibitors
|
MX2015005428A
(es)
|
2012-11-01 |
2015-07-21 |
Incyte Corp |
Derivados triciclicos fusionados de tiofeno como inhibidores de la cinasa janus (jak).
|
US10166191B2
(en)
|
2012-11-15 |
2019-01-01 |
Incyte Corporation |
Sustained-release dosage forms of ruxolitinib
|
MX2020003446A
(es)
|
2013-03-06 |
2021-07-29 |
Incyte Holdings Corp |
Procesos e intermedios para hacer un inhibidor de jak.
|
CA2911536C
(en)
|
2013-05-17 |
2021-07-20 |
Incyte Corporation |
Bipyrazole derivatives as jak inhibitors
|
PE20160223A1
(es)
|
2013-08-07 |
2016-04-27 |
Incyte Corp |
Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1
|
WO2015026818A1
(en)
|
2013-08-20 |
2015-02-26 |
Incyte Corporation |
Survival benefit in patients with solid tumors with elevated c-reactive protein levels
|
CN106456773A
(zh)
|
2014-02-28 |
2017-02-22 |
因赛特公司 |
用于治疗骨髓增生异常综合征的jak1抑制剂
|
SI3129021T1
(sl)
|
2014-04-08 |
2021-07-30 |
Incyte Corporation |
Zdravljenje malignosti B-celic s kombinacijo zaviralcev JAK in PI3K
|
CN106687462A
(zh)
|
2014-04-30 |
2017-05-17 |
因赛特公司 |
Jak1抑制剂的制备方法以及其新形式
|
EP4233870A3
(en)
|
2014-05-28 |
2024-01-24 |
Onco Tracker, Inc. |
Anti-cancer effects of jak2 inhibitors in combination with thalidomide derivatives and glucocorticoids
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
US10766900B2
(en)
|
2017-12-29 |
2020-09-08 |
Formosa Laboratories, Inc. |
Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof
|
CA3129096A1
(en)
|
2019-02-06 |
2020-08-13 |
Concert Pharmaceuticals, Inc. |
Process for preparing enantiomerically enriched jak inhibitors
|